Outpatient Surgery Magazine - Subscribers

Snuffing Out Surgical Smoke - Outpatient Surgery Magazine - December 2019

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/1191268

Contents of this Issue

Navigation

Page 104 of 156

As anesthesiologists, the 2 biggest things we do are airways — and everything else. With any new device here, I want to see how it would be different from what I already have. Is it an improvement? Is it smaller, faster, cheaper, more efficient? Is the rate of complications lower? I also come here to learn about the latest developments in the drugs we use — old drugs being reintroduced, new drugs just hitting the scene, new indications for existing drugs. Here are some of the more interesting and relevant products I saw roaming the exhibit hall at ASA 2019. OSM D E C E M B E R 2 0 1 9 • O U T PA T I E N T S U R G E R Y. N E T • 1 0 5 Dr. Sinha (drashish.sinha@gmail.com) is a professior at the University of California Riverside, and designated institutional official (DIO) and program director of anesthesiology at UC Riverside/Riverside Community Hospital. Merck & Co. Bridion merckconnect.com Each single-use vial of Bridion (sugammadex) for reversing neuromuscular blockade con- tains a concentration of 100 mg/mL of sugam- madex. Dosing is based on actual body weight and depth of block — 2 mg/kg for a moderate block and 4 mg/kg for a deep block. Vials include a peel-off label that you can apply to the syringe. Routine co-administration of an anticholinergic agent is not required, says the company. Bridion is contraindicated in patients with known hypersensitivity to sug- ammadex or any of its components.

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Subscribers - Snuffing Out Surgical Smoke - Outpatient Surgery Magazine - December 2019